Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:

Advanced search

Search projects and results

Results 1 - 10 of 25
Order by: Results/page:
12 3 > 
Sensing and controlling single molecules by novel electrical, mechanical and optical methods with applications to nanobiotechnology
ID: QLK3-CT-2001-00278
Start date: 2002-01-01, End date: 2004-12-31
This project concerns controlling and sensing single bio molecules by means of Nan electrodes and laser spectroscopy. First, the molecular position and orientation between systems of Nan electrodes will be sensed and controlled. The Nan electrodes will also act as "antennas" i...
Record Number: 64192
Last updated on: 2012-06-12
Development of human dopaminergic neuronal cell lines for transplantation
ID: QLK3-CT-2001-02120
Start date: 2001-11-01, End date: 2004-10-31
Parkinson's disease (PD) affects >1M people in the EU, and is a source of significant suffering and costs to the Community. Unlike available medical therapy, restoration of function has been demonstrated in patients receiving fatal grafts containing developing dopaminergic cel...
Record Number: 70551
Last updated on: 2005-04-12
Genetics education: improving non-genetic health professionals' understanding of genetic testing (GENED)
ID: QLG4-CT-2001-30216
Start date: 2001-12-01, End date: 2005-05-31
New genetics information and technologies are expanding rapidly. The rate of increase of trained medical geneticists and counsellors has not kept pace with genetic discoveries and demand for services. As genetic testing moves into mainstream health care tests will be administe...
Record Number: 60030
Last updated on: 2005-04-12
Microalgae as cell factories for chemical and biochemical products
ID: QLK3-CT-2002-02132
Start date: 2003-02-01, End date: 2006-01-31
There is increasing interest throughout Europe in alternative methods of obtaining chemical and biochemical products. Scientists are increasingly turning to micro algae as a natural source of many useful products. They also have many other useful properties, e.g. as a food sou...
Record Number: 68982
Last updated on: 2005-04-12
Recommendations for a future instrument for the gendersensitive assessment of health research protocols by research ethics committees (recs).
ID: QLG6-CT-2002-30616
Start date: 2003-01-01, End date: 2003-12-31
In modern medical practice, decisions regarding preventive measures, diagnostic tests and treatment possibilities are increasingly based on the results of clinical research. However, scientific evidence on health problems in women is scarce, which affects the quality of health...
Record Number: 69960
Last updated on: 2005-04-12
Fragrance chemical allergy: a major environmental and consumer health problem in europe
ID: QLK4-CT-1999-01558
Start date: 2000-02-01, End date: 2003-03-31
Sensitivity to fragrance ingredients is acknowledged as a common and clinically important problem in Europe. At least 1-2% of the general population is allergic (delayed hypersensitivity) to standard indicators of fragrance chemical allergy, which makes contact sensitisation t...
Record Number: 52810
Last updated on: 2005-04-12
Validation and standardisation of diagnostic polymerase chain reaction for detection of food-borne pathogens (FOOD-PCR)
ID: QLK1-CT-1999-00226
Start date: 2000-03-01, End date: 2003-06-30
TECHNOLOGICAL PROBLEM Recognising that sensitive and more cost-effective methods are needed for detecting food-borne pathogens, we are launching a project seeking to validate and standardise use of the polymerase chain reaction (PCR) for this purpose. Although a powerful rese...
Record Number: 51463
Last updated on: 2005-04-12
Characterization of a new model of parkinson's diisease induced by expression of alpha-synuclein in the midbrain.
ID: QLK6-CT-2001-51860
Start date: 2002-08-01, End date: 2004-07-31
Temporal biochemical, molecular and behavioural characterization of the new Parkinson model. Study of the potential of GDNF retrovirus as a therapeutic strategy. Analysis of the susceptibility to 6-OH-dopamine of the dopaminergic system in the model.
Record Number: 70362
Last updated on: 2005-04-12
Gene therapy of hematopoietic stem cells for inherited diseases
ID: QLK3-CT-2001-00427
Start date: 2002-01-01, End date: 2004-12-31
INHERINET aims to develop novel, safe and curative treatments based on therapeutic gene transfer into antilogous (i.e., patient-derived) haematopoietic stem cells for selected example hereditary diseases, which include immunodeficiency's, mucopolysaccharidosis VI, Diamond-Blac...
Record Number: 64550
Last updated on: 2005-04-12
Novel in vitro testing platforms based on intra-and extracellular sensing
ID: QLK3-CT-2001-00244
Start date: 2002-01-01, End date: 2004-12-31
The goal of the project is to develop new in-vitro platforms for pharmaceutical screening based on animal or human cells grown on microelectrode arrays enabling simultaneous monitoring of extra- and intracellular levels of key metabolites (e.g., NO and super oxide) by using op...
Record Number: 64198
Last updated on: 2005-04-12
12 3 > 
List retrieved on: 2018-08-21
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top